| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 10.122 | 36.223 | 44.646 | 54.816 | 71.669 | 140.741 | 182.541 | 211.543 | 188.225 | 230.471 |
| Total Income - EUR | 10.122 | 36.224 | 44.648 | 54.817 | 71.910 | 143.893 | 182.546 | 211.550 | 188.227 | 230.495 |
| Total Expenses - EUR | 5.135 | 29.046 | 17.409 | 21.559 | 33.099 | 41.843 | 69.514 | 89.766 | 98.768 | 99.519 |
| Gross Profit/Loss - EUR | 4.988 | 7.178 | 27.239 | 33.258 | 38.811 | 102.050 | 113.031 | 121.783 | 89.459 | 130.976 |
| Net Profit/Loss - EUR | 4.684 | 6.816 | 26.792 | 32.709 | 38.092 | 100.611 | 111.242 | 119.714 | 87.615 | 125.530 |
| Employees | 5 | 2 | 2 | 0 | 2 | 2 | 0 | 1 | 1 | 2 |
Check the financial reports for the company - Neuropshy Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.349 | 2.748 | 5.844 | 11.092 | 13.950 | 26.369 | 55.562 | 41.842 | 29.382 | 17.488 |
| Current Assets | 7.601 | 7.965 | 21.228 | 23.565 | 21.874 | 74.186 | 65.514 | 152.658 | 69.960 | 199.169 |
| Inventories | 7 | 4 | 0 | 2.152 | 0 | 18 | 207 | 0 | 0 | 0 |
| Receivables | 3.468 | 1.987 | 3.429 | 4.515 | 6.953 | 11.693 | 23.387 | 93.809 | 38.777 | 19.217 |
| Cash | 4.126 | 5.974 | 17.799 | 16.898 | 14.920 | 62.475 | 41.920 | 58.850 | 31.183 | 179.952 |
| Shareholders Funds | 4.729 | 6.869 | 26.845 | 32.761 | 49.184 | 100.660 | 111.291 | 119.762 | 87.663 | 212.703 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.221 | 3.844 | 3.189 | 14.202 | 1.701 | 4.419 | 12.522 | 77.483 | 11.679 | 4.437 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Neuropshy Med Srl